A double-blind placebo-controlled dose-finding trial to evaluate the efficacy and safety of R093877 [prucalopride] in patients with chronic idiopathic constipation

Trial Profile

A double-blind placebo-controlled dose-finding trial to evaluate the efficacy and safety of R093877 [prucalopride] in patients with chronic idiopathic constipation

Completed
Phase of Trial: Phase II

Latest Information Update: 10 May 2011

At a glance

  • Drugs Prucalopride (Primary)
  • Indications Constipation
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Shire-Movetis NV
  • Most Recent Events

    • 10 May 2011 Pooled results of three phase II trials [see trial profiles 700030527, 700032139 and 700199472] presented at the Digestive Disease Week 2011.
    • 02 Apr 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top